Clinical Trial Podcast | Conversations with Clinical Research Experts Complexity in Early Phase Clinical Trials with Dr. Oren Cohen
Sep 26, 2022
AI Snips
Chapters
Transcript
Episode notes
Evolving Complexity in Phase 1 Trials
- Early phase clinical trials are becoming more complex, often involving multiple sites and patient populations.
- This shift is driven by the need to accelerate drug development and gather broader data earlier.
Accelerated COVID-19 Drug Development
- Dr. Cohen recounts Labcorp's rapid COVID-19 drug development during the pandemic.
- Collaboration with MHRA and a streamlined process compressed a year-long study into 16 weeks.
Tips for Sponsor-CRO-Regulatory Collaboration
- Establish well-defined sponsor and CRO teams early in the process.
- Foster close collaboration with regulatory authorities for real-time feedback and guidance.